Skip to content

Net Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$77.9M-189%
Glaukos logo
GlaukosGKOS
-$19.78M-9.0%
AbbVie logo
AbbVieABBV
$695M-46.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
Solventum logo
SolventumSOLV
$13M-90.5%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%
Enterprise value$10.06B+6.9%
P/S0.0×

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's net income?
Bausch + Lomb (BLCO) reported net income of -$71M in Q1 2026.
How has Bausch + Lomb's net income changed year-over-year?
Bausch + Lomb's net income increased by 66.5% year-over-year, from -$212M to -$71M.
What is the long-term trend for Bausch + Lomb's net income?
Over 4 years (2021 to 2025), Bausch + Lomb's net income has grown at a 18.6% compound annual growth rate (CAGR), from $182M to -$360M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.